DRG Epidemiology’s coverage of acute heart failure (AHF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed incidence of AHF hospitalizations for each country, as well as annualized event counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan and 10 years for the other countries covered in this report.
DRG Epidemiology’s AHF forecast will answer the following questions:
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of AHF over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods. In addition, we provide a graph of the patient flow between or within different disease states for the countries considered in this report. These patient-flow diagrams are provided at the regional level but may be requested for any specific country or forecast year.
In total, DRG Epidemiology forecasts the following AHF patient population:
Hospitalization Rates for Acute Heart Failure per Year per 1,000 People Aged 20+ in 2021 and 2041
Relative Sizes of the Contributing Factors to the Trend in AHF Events Over the Next 10 Years
Analysis of Hospitalization Events for Acute Heart Failure in 2021 by Drug-Treated Status
Analysis of Hospitalization Events for Acute Heart Failure in 2021 by Drug-Treated Status
Epidemiology Data
Methods
Diagnosed Events
Drug-Treated Events
Reference Materials
Literature Review
Studies Included in the Analysis of Acute Heart Failure
Studies Excluded from the Analysis of Acute Heart Failure
Risk/Protective Factors
Risk/Protective Factors for Acute Heart Failure
Bibliography
Abbreviations
Glossary
Sunali D. Goonesekera, S.M.
Sunali Goonesekera, S.M., is a senior epidemiologist at Clarivate. Previously, Ms. Goonesekera conducted epidemiological research on racial/ethnic disparities in metabolic diseases at the New England Research Institute and lead-authored two manuscripts. She has contributed to multiple publications in peer-reviewed journals in epidemiology and the biological sciences. She holds a master’s degree in epidemiology from the Harvard School of Public Health and a B.A. in biology (Honors) from Dartmouth College.
Aarushi Kashyap, M.Tech.
Aarushi Kashyap is a Senior Insights Analyst in Oncology team at Decision Resources Group, based out of Gurgaon office in India.
She comes with a work experience of 4 years as Business Analyst with practice across multiple oncology indications in various functions in Competitive Intelligence and Secondary Research, including pipeline analysis, competitive product reporting, clinical trials assessment and benchmarking, clinical and competitor landscaping, therapy area deep dive reporting, ad-hoc news tracking etc. She has attended various big and small oncology medical congresses across US and Europe in parallel to creating pre- and post-conference data summaries with implications and schedule trackers for abstracts of interest delivering to directly to clients. She has earned her Master’s and Bachelor’s in Technology in Biotechnology from Jaypee Institute of Information Technology University.
